Compare EYPT & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EYPT | CLOV |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2005 | N/A |
| Metric | EYPT | CLOV |
|---|---|---|
| Price | $16.10 | $2.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $29.60 | $4.23 |
| AVG Volume (30 Days) | 1.1M | ★ 4.6M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $42,339,000.00 | ★ $1,773,564,000.00 |
| Revenue This Year | N/A | $41.68 |
| Revenue Next Year | N/A | $37.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 32.15 |
| 52 Week Low | $3.91 | $2.12 |
| 52 Week High | $19.11 | $4.87 |
| Indicator | EYPT | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 60.28 | 53.81 |
| Support Level | $15.97 | $2.41 |
| Resistance Level | $19.11 | $2.80 |
| Average True Range (ATR) | 0.96 | 0.10 |
| MACD | 0.11 | 0.05 |
| Stochastic Oscillator | 46.36 | 83.50 |
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.